ASSET PURCHASE AGREEMENT between AVANT DIAGNOSTICS, INC. and ONCBIOMUNE PHARMACEUTICALS, INC. dated as of May 12, 2020Asset Purchase Agreement • May 13th, 2020 • OncBioMune Pharmaceuticals, Inc • Pharmaceutical preparations • Nevada
Contract Type FiledMay 13th, 2020 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”), dated as of May 12, 2020, is made and entered into by and between Avant Diagnostics, Inc., a Nevada corporation (“Seller”) and Oncbiomune Pharmaceuticals, Inc., a Nevada corporation (“Buyer”). Buyer and Seller are each a “Party” and collectively the “Parties.”